Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Breast Neoplasms 78Neoplasm Metastasis 16Neoplasms 9Breast Neoplasms, Male 9Brain Neoplasms 6Urinary Bladder Neoplasms 5Ovarian Neoplasms 5Head and Neck Neoplasms 4Colorectal Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Prostatic Neoplasms 3Lung Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Ovarian Epithelial 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Pancreatic Neoplasms 2Neuroma, Acoustic 2Neurofibromatosis 2 2Inflammatory Breast Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Ductal, Breast 2Salivary Gland Neoplasms 1Recurrence 1Prolactinoma 1Pituitary Neoplasms 1Patient Compliance 1Neuroectodermal Tumors, Primitive 1

Interventions

Paclitaxel 2tremelimumab 1pegfilgrastim 1durvalumab 1Taxes 1Sunitinib 1Lapatinib 1Ifosfamide 1Darbepoetin alfa 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dysgerminoma × Lapatinib × Clear all
NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

University of California, San Francisco

Phase 1 Completed
28 enrolled
BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡